Twenty-five patients aged 10 to 19 years with TG levels 150 to 1000 mg/dL were randomized to 6 months double-blind trial of Lovaza ( ~ 3360 mg docosahexaenoic acid + eicosapentaenoic acid per day ) versus placebo .